Myriad Genetics | MYGN - Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Agilent USD 465M 11M 2026-03
Becton, Dickinson and Co. USD 1.26B 48M 2026-06
Bio-Rad Laboratories USD 212M 400K 2026-06
Bruker USD 238.9M 3.2M 2026-06
Danaher USD 2.07B 212M 2026-06
Illumina USD 273M 1000K 2026-06
J&J USD 6.42B 381M 2026-06
Mettler Toledo International USD 263.33M 5.01M 2026-06
Myriad Genetics USD 122.3M 6.7M 2025-12
OraSure Technologies USD 13.21M 3.29M 2025-12
Pacific Biosciences Of California USD 37.24M 25.68M 2025-12
Quest Diagnostics USD 529M 25M 2026-06
Quidel USD 189.7M 9.6M 2026-06
Repligen USD 76.62M 82K 2026-06
Revvity USD 278.58M 24.69M 2026-06
Standard Biotools USD 18.61M 2.94M 2026-03
Thermo Fisher Scientific USD 1.91B 111M 2026-06
Veracyte USD 55.71M 4.87M 2026-06
Waters USD 405M 11M 2026-06